D.A. Davidson & Co’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-3,833
| Closed | -$14K | – | 2316 |
|
2017
Q2 | $14K | Sell |
3,833
-2,900
| -43% | -$10.6K | ﹤0.01% | 1943 |
|
2017
Q1 | $27K | Buy |
6,733
+1,035
| +18% | +$4.15K | ﹤0.01% | 1748 |
|
2016
Q4 | $24K | Buy |
5,698
+331
| +6% | +$1.39K | ﹤0.01% | 1875 |
|
2016
Q3 | $52K | Buy |
5,367
+200
| +4% | +$1.94K | ﹤0.01% | 1513 |
|
2016
Q2 | $29K | Buy |
5,167
+1,430
| +38% | +$8.03K | ﹤0.01% | 1632 |
|
2016
Q1 | $28K | Hold |
3,737
| – | – | ﹤0.01% | 1608 |
|
2015
Q4 | $49K | Sell |
3,737
-19,439
| -84% | -$255K | ﹤0.01% | 1400 |
|
2015
Q3 | $381K | Sell |
23,176
-1,343
| -5% | -$22.1K | 0.01% | 618 |
|
2015
Q2 | $550K | Buy |
+24,519
| New | +$550K | 0.02% | 547 |
|